Serum leptin levels in patients with hyperlipidemias

Area of Science:

• Endocrinology
• Metabolic Disorders
• Lipid Metabolism

Background:

• Leptin, a protein hormone from adipocytes, indicates body fat content.
• Hypercholesterolemia and combined hyperlipidemia are common lipid disorders.
• Understanding leptin's role in dyslipidemia is crucial for metabolic health.

Purpose of the Study:

• To compare serum leptin levels between hyperlipidemic patients and healthy controls.
• To investigate the relationship between leptin and serum lipids/lipoproteins.
• To analyze sex-based differences in leptin levels concerning lipid profiles.

Main Methods:

• Serum leptin levels were measured in untreated males and females with hypercholesterolemia or combined hyperlipidemia.
• Control groups of healthy males and females were matched for age and body mass index (BMI).
• Statistical analyses were performed to compare leptin levels and correlate them with lipid parameters.

Main Results:

• No significant differences in serum leptin levels were found between hyperlipidemic and control groups when matched for age and BMI.
• Leptin levels were generally lower in males than females across all groups.
• Leptin positively correlated with BMI in most groups; negative correlations with HDL cholesterol were observed in specific subgroups, while positive correlations were found in others.

Conclusions:

• Serum leptin levels in hyperlipidemia patients are comparable to age- and BMI-matched healthy individuals.
• Sex differences in leptin levels persist regardless of lipid disorder status.
• Leptin exhibits complex correlations with BMI and specific lipoproteins, varying by sex and lipid profile.